Damania Pharma Ltd

Damania Pharma Ltd - chemicals in Ahmednagar, Maharashtra, India. FY 2026 financials and compliance.
CIN U24232MH1992PTC066223 Incorporated 06 April 1992 ROC Pune HQ Ahmednagar, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2017
-
Latest filing
EBITDA · FY 2017
*****
▲ 0.00% YoY
Net profit · FY 2017
*****
In full report
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
34 yrs
Est. 1992
Last financials
Mar 2017
Balance sheet date

About Damania Pharma Ltd

Data last updated: 07 March 2026

Damania Pharma Ltd is a private limited company based in Ahmednagar, Maharashtra, India. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 06 April 1992, the company has been in operation for over 34 years.

Registered with ROC Pune under CIN U24232MH1992PTC066223.

Capital: an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Hemang Pravinchandra Kapadia and Sampat Sadashiv Sonde.

Last AGM: 29 September 2017. Financial statements filed for year ended 31 March 2017. Office: Flat No. 9 Dinshaw Plaza 165 Jamkhed Road, Ahmednagar, Maharashtra, India – 414002.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Damania Pharma Ltd
CIN U24232MH1992PTC066223
Registration Number 066223
Incorporation Date 06 April 1992
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2017
Date of Balance Sheet 31 March 2017
Compliance Status Active Non-Compliant
Key People
Hemang Pravinchandra Kapadia Director Sampat Sadashiv Sonde Director Sachin Chandrakant Thakur Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Flat No. 9 Dinshaw Plaza 165 Jamkhed Road, Ahmednagar, Maharashtra, India – 414002
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Company report
Damania Pharma Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Damania Pharma Ltd report

Financials, compliance, directors, charges, ownership and filings for Damania Pharma Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Damania Pharma Ltd

Damania Pharma Ltd is audited by K LAHAMGE & R DAREKAR for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
K LAHAMGE & R DAREKAR blur-value blur-value blur-value

Board of Directors of Damania Pharma Ltd

Damania Pharma Ltd is currently managed by 5 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Hemang Pravinchandra Kapadia
Also directs: Damania Capital Markets Limited
Director 30 Sep 2002 23 Years 9 Months Current
Sampat Sadashiv Sonde Director 01 Oct 2005 20 Years 9 Months Current
Sachin Chandrakant Thakur
Also directs: Karan Layer Farm Products Limited, Damania Capital Markets Limited
Director 30 Sep 2002 23 Years 9 Months Current
Parvez Cavas Damania
Also directs: Shivdutt Das Art Foundation, Paar Aviation Private Limited
Director 01 Jan 2001 25 Years 6 Months Current
Surendra Babu Singh
Also directs: Damania Capital Markets Limited
Director 30 Sep 2002 23 Years 9 Months Current
View all directors

Financials of Damania Pharma Ltd FY 2017 filings available

Damania Pharma Ltd reported revenue of ₹- (up ) for FY 2017. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
EBITDA
*****
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Damania Pharma Ltd

As of FY 2017, Damania Pharma Ltd's shareholding pattern shows 100.00% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Damania Pharma Ltd

Damania Pharma Ltd does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Damania Pharma Ltd

View historical data on people associated with Damania Pharma Ltd, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Damania Pharma Ltd

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Damania Pharma Ltd

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Damania Pharma Ltd

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Damania Pharma Ltd

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Damania Pharma Ltd

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Damania Pharma Ltd

MSME Payment Delays by Damania Pharma Ltd

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Damania Pharma Ltd

Subsidiaries & Group Companies of Damania Pharma Ltd

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Damania Pharma Ltd with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Damania Pharma Ltd

MCA Filings & Documents of Damania Pharma Ltd

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Damania Pharma Ltd

Activity
29 Sep 2017
Damania Pharma Ltd last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.
Activity
31 Mar 2017
Damania Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Pune.
Directors
01 Oct 2005
Sampat Sadashiv Sonde was appointed as a Director on 01 Oct 2005 & has been associated with this company since 20 years 9 months.
Directors
30 Sep 2002
Hemang Pravinchandra Kapadia was appointed as a Director on 30 Sep 2002 & has been associated with this company since 23 years 9 months.
Directors
30 Sep 2002
Sachin Chandrakant Thakur was appointed as a Director on 30 Sep 2002 & has been associated with this company since 23 years 9 months.
Directors
30 Sep 2002
Surendra Babu Singh was appointed as a Director on 30 Sep 2002 & has been associated with this company since 23 years 9 months.

Frequently Asked Questions about Damania Pharma Ltd

Damania Pharma Ltd is an active private limited company in the chemicals sector based in Ahmednagar, Maharashtra, India. It was incorporated on 06 April 1992 (34+ years old) and is registered under CIN U24232MH1992PTC066223.

The current directors of Damania Pharma Ltd are:

The primary industry of Damania Pharma Ltd is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.

Damania Pharma Ltd can be reached at the registered office: Flat No. 9 Dinshaw Plaza 165 Jamkhed Road, Ahmednagar, Maharashtra, India – 414002.

The authorised capital is ₹3.5 Cr, and the paid-up capital is ₹3 Cr.

The company has its registered office at Flat No. 9 Dinshaw Plaza 165 Jamkhed Road, Ahmednagar, Maharashtra, India – 414002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available